APO RESEARCH · REPORT
Mildronate Dihydrate
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
Product & engineering
Understand the product.
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
Selected research
Market Outlook & Growth Opportunities
Global Mildronate Dihydrate Market Outlook and Growth Opportunities 2026
Market perspective
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
In Europe, Mildronate Dihydrate key players include Grindeks, etc. Global top one manufacturers hold a share over 99%.
Russia is the largest market, with a share about 40%, followed by Latvia, and Lithuania, both have a share over 5 percent.
Read the full market overview
In terms of product, Capsule is the largest segment, with a share over 55%. And in terms of application, the largest application is Cardiovascular Disease, etc.
This report provides an overview of the global Mildronate Dihydrate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Mildronate Dihydrate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Mildronate Dihydrate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mildronate Dihydrate market size, projected growth trends, production technologies, key applications, and end-use industries.
Mildronate Dihydrate Segment by Company
Grindeks
Mildronate Dihydrate Segment by Type
Capsule
Injection
Tablet
Mildronate Dihydrate Segment by Application
Cardiovascular Disease
Others
Mildronate Dihydrate Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Mildronate Dihydrate status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Mildronate Dihydrate market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Mildronate Dihydrate significant trends, drivers, influence factors in global and regions.
6. To analyze Mildronate Dihydrate competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mildronate Dihydrate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mildronate Dihydrate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mildronate Dihydrate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Mildronate Dihydrate market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mildronate Dihydrate industry.
Chapter 3: Detailed analysis of Mildronate Dihydrate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Mildronate Dihydrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Mildronate Dihydrate in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Capsule
- Injection
- Tablet
Applications
- Cardiovascular Disease
- Others
Companies covered
- Grindeks
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Mildronate Dihydrate Sales Value (2021-2032)
- 1.2.2 Global Mildronate Dihydrate Sales Volume (2021-2032)
- 1.2.3 Global Mildronate Dihydrate Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Mildronate Dihydrate Market Dynamics
- 2.1 Mildronate Dihydrate Industry Trends
- 2.2 Mildronate Dihydrate Industry Drivers
- 2.3 Mildronate Dihydrate Industry Opportunities and Challenges
- 2.4 Mildronate Dihydrate Industry Restraints
3 Mildronate Dihydrate Market by Company
- 3.1 Global Mildronate Dihydrate Company Revenue Ranking in 2025
- 3.2 Global Mildronate Dihydrate Revenue by Company (2021-2026)
- 3.3 Global Mildronate Dihydrate Sales Volume by Company (2021-2026)
- 3.4 Global Mildronate Dihydrate Average Price by Company (2021-2026)
- 3.5 Global Mildronate Dihydrate Company Ranking (2024-2026)
- 3.6 Global Mildronate Dihydrate Company Manufacturing Base and Headquarters
- 3.7 Global Mildronate Dihydrate Company Product Type and Application
- 3.8 Global Mildronate Dihydrate Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Mildronate Dihydrate Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Mildronate Dihydrate Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Mildronate Dihydrate Market by Type
- 4.1 Mildronate Dihydrate Type Introduction
- 4.1.1 Capsule
- 4.1.2 Injection
- 4.1.3 Tablet
- 4.2 Global Mildronate Dihydrate Sales Volume by Type
- 4.2.1 Global Mildronate Dihydrate Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Mildronate Dihydrate Sales Volume by Type (2021-2032)
- 4.2.3 Global Mildronate Dihydrate Sales Volume Share by Type (2021-2032)
- 4.3 Global Mildronate Dihydrate Sales Value by Type
- 4.3.1 Global Mildronate Dihydrate Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Mildronate Dihydrate Sales Value by Type (2021-2032)
- 4.3.3 Global Mildronate Dihydrate Sales Value Share by Type (2021-2032)
5 Mildronate Dihydrate Market by Application
- 5.1 Mildronate Dihydrate Application Introduction
- 5.1.1 Cardiovascular Disease
- 5.1.2 Others
- 5.2 Global Mildronate Dihydrate Sales Volume by Application
- 5.2.1 Global Mildronate Dihydrate Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Mildronate Dihydrate Sales Volume by Application (2021-2032)
- 5.2.3 Global Mildronate Dihydrate Sales Volume Share by Application (2021-2032)
- 5.3 Global Mildronate Dihydrate Sales Value by Application
- 5.3.1 Global Mildronate Dihydrate Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Mildronate Dihydrate Sales Value by Application (2021-2032)
- 5.3.3 Global Mildronate Dihydrate Sales Value Share by Application (2021-2032)
6 Mildronate Dihydrate Regional Sales and Value Analysis
- 6.1 Global Mildronate Dihydrate Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Mildronate Dihydrate Sales by Region (2021-2032)
- 6.2.1 Global Mildronate Dihydrate Sales by Region: 2021-2026
- 6.2.2 Global Mildronate Dihydrate Sales by Region (2027-2032)
- 6.3 Global Mildronate Dihydrate Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Mildronate Dihydrate Sales Value by Region (2021-2032)
- 6.4.1 Global Mildronate Dihydrate Sales Value by Region: 2021-2026
- 6.4.2 Global Mildronate Dihydrate Sales Value by Region (2027-2032)
- 6.5 Global Mildronate Dihydrate Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Mildronate Dihydrate Sales Value (2021-2032)
- 6.6.2 North America Mildronate Dihydrate Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Mildronate Dihydrate Sales Value (2021-2032)
- 6.7.2 Europe Mildronate Dihydrate Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Mildronate Dihydrate Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Mildronate Dihydrate Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Mildronate Dihydrate Sales Value (2021-2032)
- 6.9.2 South America Mildronate Dihydrate Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Mildronate Dihydrate Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Mildronate Dihydrate Sales Value Share by Country, 2025 VS 2032
7 Mildronate Dihydrate Country-level Sales and Value Analysis
- 7.1 Global Mildronate Dihydrate Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Mildronate Dihydrate Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Mildronate Dihydrate Sales by Country (2021-2032)
- 7.3.1 Global Mildronate Dihydrate Sales by Country (2021-2026)
- 7.3.2 Global Mildronate Dihydrate Sales by Country (2027-2032)
- 7.4 Global Mildronate Dihydrate Sales Value by Country (2021-2032)
- 7.4.1 Global Mildronate Dihydrate Sales Value by Country (2021-2026)
- 7.4.2 Global Mildronate Dihydrate Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.9.2 France Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.16.2 China Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.19.2 India Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Mildronate Dihydrate Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Mildronate Dihydrate Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Mildronate Dihydrate Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Grindeks
- 8.1.1 Grindeks Company Information
- 8.1.2 Grindeks Business Overview
- 8.1.3 Grindeks Mildronate Dihydrate Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Grindeks Mildronate Dihydrate Product Portfolio
- 8.1.5 Grindeks Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Mildronate Dihydrate Value Chain Analysis
- 9.1.1 Mildronate Dihydrate Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Mildronate Dihydrate Sales Mode & Process
- 9.2 Mildronate Dihydrate Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Mildronate Dihydrate Distributors
- 9.2.3 Mildronate Dihydrate Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst